<SEC-DOCUMENT>0001753926-24-000105-index.html : 20240116
<SEC-HEADER>0001753926-24-000105.hdr.sgml : 20240116
<ACCEPTANCE-DATETIME>20240116172802
ACCESSION NUMBER:		0001753926-24-000105
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20240116
DATE AS OF CHANGE:		20240116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chromocell Therapeutics Corp
		CENTRAL INDEX KEY:			0001919246
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				863335449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-269188
		FILM NUMBER:		24536154

	BUSINESS ADDRESS:	
		STREET 1:		685 US HIGHWAY ONE
		CITY:			NORTH BRUNSWICK
		STATE:			NJ
		ZIP:			08902
		BUSINESS PHONE:		9176446313

	MAIL ADDRESS:	
		STREET 1:		685 US HIGHWAY ONE
		CITY:			NORTH BRUNSWICK
		STATE:			NJ
		ZIP:			08902
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>g083881_s1a.htm
<DESCRIPTION>S-1/A
<TEXT>
Document 1 - file: g083881_s1a.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.21 <SEQUENCE>2 <FILENAME>g083881_ex4-21.htm <DESCRIPTION>EXHIBIT 4.21 <TEXT> Document 2 - file: g083881_ex4-21.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.22 <SEQUENCE>3 <FILENAME>g083881_ex4-22.htm <DESCRIPTION>EXHIBIT 4.22 <TEXT> Document 3 - file: g083881_ex4-22.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.23 <SEQUENCE>4 <FILENAME>g083881_ex4-23.htm <DESCRIPTION>EXHIBIT 4.23 <TEXT> Document 4 - file: g083881_ex4-23.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.24 <SEQUENCE>5 <FILENAME>g083881_ex4-24.htm <DESCRIPTION>EXHIBIT 4.24 <TEXT> Document 5 - file: g083881_ex4-24.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.25 <SEQUENCE>6 <FILENAME>g083881_ex4-25.htm <DESCRIPTION>EXHIBIT 4.25 <TEXT> Document 6 - file: g083881_ex4-25.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.26 <SEQUENCE>7 <FILENAME>g083881_ex4-26.htm <DESCRIPTION>EXHIBIT 4.26 <TEXT> Document 7 - file: g083881_ex4-26.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.27 <SEQUENCE>8 <FILENAME>g083881_ex4-27.htm <DESCRIPTION>EXHIBIT 4.27 <TEXT> Document 8 - file: g083881_ex4-27.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.28 <SEQUENCE>9 <FILENAME>g083881_ex4-28.htm <DESCRIPTION>EXHIBIT 4.28 <TEXT> Document 9 - file: g083881_ex4-28.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.29 <SEQUENCE>10 <FILENAME>g083881_ex4-29.htm <DESCRIPTION>EXHIBIT 4.29 <TEXT> Document 10 - file: g083881_ex4-29.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.13 <SEQUENCE>11 <FILENAME>g083881_ex10-13.htm <DESCRIPTION>EXHIBIT 10.13 <TEXT> Document 11 - file: g083881_ex10-13.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.14 <SEQUENCE>12 <FILENAME>g083881_ex10-14.htm <DESCRIPTION>EXHIBIT 10.14 <TEXT> Document 12 - file: g083881_ex10-14.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>13 <FILENAME>g083881_ex23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 13 - file: g083881_ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>14 <FILENAME>g083881_ex107.htm <DESCRIPTION>EXHIBIT 107 <TEXT> Document 14 - file: g083881_ex107.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>15 <FILENAME>img001_v1.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 15 - file: img001_v1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>16 <FILENAME>img002_v1.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 16 - file: img002_v1.jpg
</DOCUMENT> </SEC-DOCUMENT>